Yoon Park

8PUBLICATIONS

21CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 12, 2026

Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

|Mar 12, 2025

Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma.

Seok Jin Kim, Jing Quan Lim, Sang Eun Yoon

|Sep 30, 2024

Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.

Yunju Jo, Hye-In Sim, Bohwan Yun

|Oct 20, 2023

A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.

Dong-Hee Lee, Hyejin Ahn, Hye-In Sim

|Feb 01, 2023

The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma.

Sang Eun Yoon, Woorim Kang, Seunghyun Choi

|Jan 23, 2023

Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules.

Eun Young Jeon, Da-Som Choi, Seunghyun Choi

Pageof 2

Frequent Collaborators

Hyung-Seung Jin

Seok Jin Kim

Ju-Young Won

Youngmee Jung

Hae Woong Choi

Hojun Sung

Jing Quan Lim

Sang Eun Yoon

Sung Yong Oh

Yoon Seok Choi

Frequent Collaborators

Hyung-Seung Jin

Seok Jin Kim

Ju-Young Won

Youngmee Jung